Skip to main content
Wanbury Limited logo

Wanbury Limited — Investor Relations & Filings

Ticker · WANBURY ISIN · INE107F01022 LEI · 335800QB384KGMBID276 BSE.NS Manufacturing
Open in API
Filings indexed 912 across all filing types
Latest filing 2026-02-05 Regulatory Filings
Country IN India
Listing BSE.NS WANBURY

About Wanbury Limited

https://www.wanbury.com

Wanbury Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and finished formulations. The organization maintains a significant global presence, particularly as a leading producer of Metformin. Its product portfolio spans diverse therapeutic areas, including gynecology, orthopedics, hematinics, and anti-diabetics. The company operates manufacturing facilities compliant with international regulatory standards, including the USFDA. Wanbury focuses on providing medicinal solutions through integrated research and development capabilities and large-scale production infrastructure, serving both domestic and international markets with a range of specialty products.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Regulatory Filings Classification · 85% confidence The document is an official stock-exchange submission under SEBI Listing Regulations announcing the outcomes of a Board meeting held on February 5, 2026. It provides notice of (i) approval of un-audited Q3/9M results (to be uploaded separately), (ii) ESOP grants and share allotment, and (iii) change in paid-up capital. It does not include the actual financial statements, nor is it a management change, earnings release with key highlights only, or a full interim report. It is a general regulatory announcement of board meeting outcomes and related capital changes under Indian listing rules, fitting the “Regulatory Filings” (RNS) fallback category.
2026-02-05 English
Press Release with titled "Wanbury Achieves First Sales Invoicing and commercial shipment milestone on 30th January, 2026 for the new Product, High-Demand Anaesthetic API-Production Ramp-Up ....
Regulatory Filings
2026-02-03 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release dated February 3, 2026, from Wanbury Limited announcing a milestone achievement of first sales invoicing and commercial shipment for a new product. It is addressed to stock exchanges and includes a summary of the company's business and contact information. The document does not contain financial statements, detailed financial analysis, or regulatory filings such as annual or quarterly reports. It is a corporate announcement informing the market about a business milestone and operational progress. The length is 8735 characters, which is substantial but the content is clearly a press release rather than a full financial report or regulatory filing. Therefore, it fits best under the category of Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2026-02-03 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2026-01-28 English
Wanbury Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2026 ,inter alia, to consider and approve Intimation of Board Meeting under Regulation ....
Regulatory Filings
2026-01-28 English
Board Meeting — Financial Results
Regulatory Filings Classification · 90% confidence The document text is extremely short (583 characters) and consists solely of a digital signature block with no substantive content related to financial reports, announcements, or filings. There is no indication of any report, announcement, or regulatory filing content. Given the lack of any report or announcement content, and the presence of a digital signature, this document most closely fits the category of a Regulatory Filing (RNS) as a fallback for miscellaneous filings that do not fit other categories.
2026-01-28 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.